NASDAQ:SYNH - Syneos Health Stock Price, Forecast & News

Syneos Health trades on the NASDAQ under the ticker symbol "SYNH."

Syneos Health Inc (NASDAQ:SYNH) announced its earnings results on Thursday, October, 31st. The company reported $0.87 EPS for the quarter, beating analysts' consensus estimates of $0.82 by $0.05. The company earned $1.18 billion during the quarter, compared to the consensus estimate of $1.18 billion. Syneos Health had a return on equity of 10.13% and a net margin of 1.86%. The firm's revenue for the quarter was up 5.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.75 earnings per share. View Syneos Health's Earnings History.

Syneos Health is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Syneos Health.

Syneos Health issued an update on its FY 2020 After-Hours earnings guidance on Wednesday, January, 15th. The company provided EPS guidance of 3.58-3.78 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.59. The company issued revenue guidance of $4.88-5 billion, compared to the consensus revenue estimate of $4.94 billion.

10 brokers have issued 1 year price targets for Syneos Health's shares. Their forecasts range from $48.00 to $75.00. On average, they anticipate Syneos Health's stock price to reach $64.50 in the next twelve months. This suggests a possible upside of 0.8% from the stock's current price. View Analyst Price Targets for Syneos Health.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Syneos Health in the last year. There are currently 3 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Syneos Health.

Press coverage about SYNH stock has trended extremely negative on Monday, according to InfoTrie Sentiment. The research firm identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Syneos Health earned a news impact score of -5.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Syneos Health.

Some companies that are related to Syneos Health include Incyte (INCY), EXACT Sciences (EXAS), Icon (ICLR), Charles River Laboratories Intl. (CRL), PRA Health Sciences (PRAH), Exelixis (EXEL), BTG (BTGGF), Medpace (MEDP), National Research (NRC), Intrexon (XON), Sorrento Therapeutics (SRNE), Auxly Cannabis Group (CBWTF), STARPHARMA HOLD/S (SPHRY), Luna Innovations (LUNA) and Anavex Life Sciences (AVXL).

Based on aggregate information from My MarketBeat watchlists, some companies that other Syneos Health investors own include AT&T (T), NVIDIA (NVDA), Icon (ICLR), Jazz Pharmaceuticals (JAZZ), Netflix (NFLX), Skyworks Solutions (SWKS), Alibaba Group (BABA), Square (SQ), Constellation Brands (STZ) and UnitedHealth Group (UNH).

Syneos Health's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Peregrine Capital Management LLC (0.63%), Hennessy Advisors Inc. (0.26%), Bowling Portfolio Management LLC (0.03%), Louisiana State Employees Retirement System (0.01%), State of Alaska Department of Revenue (0.01%) and Nisa Investment Advisors LLC (0.01%). Company insiders that own Syneos Health stock include Alistair Macdonald, Christopher L Gaenzle, H Lee Equity Fund Vi Thomas, Jason M Meggs and Jonathan Olefson. View Institutional Ownership Trends for Syneos Health.

SYNH stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Nisa Investment Advisors LLC, State of Alaska Department of Revenue and First Hawaiian Bank. View Insider Buying and Selling for Syneos Health.

SYNH stock was bought by a variety of institutional investors in the last quarter, including Hennessy Advisors Inc., Bowling Portfolio Management LLC, Allred Capital Management LLC, Alpha Windward LLC and Louisiana State Employees Retirement System. Company insiders that have bought Syneos Health stock in the last two years include Jason M Meggs and Jonathan Olefson. View Insider Buying and Selling for Syneos Health.

Shares of SYNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SYNH stock can currently be purchased for approximately $63.99.

Syneos Health has a market capitalization of $6.64 billion and generates $4.39 billion in revenue each year. The company earns $24.28 million in net income (profit) each year or $2.62 on an earnings per share basis. Syneos Health employs 24,000 workers across the globe.View Additional Information About Syneos Health.

The official website for Syneos Health is http://www.syneoshealth.com/.

Syneos Health's mailing address is 1030 Sync Street, Morrisville NC, 27560. The company can be reached via phone at 919-876-9300 or via email at [email protected]